Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11,242 GBX | -0.07% | +3.59% | +6.30% |
03:38pm | AstraZeneca's Voydeya Approved as Add-on Therapy in Europe for Blood Disorder | MT |
10:50am | ASTRAZENECA : JP Morgan reaffirms its Buy rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.30% | 215B | |
+26.07% | 659B | |
+26.74% | 557B | |
-5.08% | 359B | |
+17.08% | 322B | |
+9.34% | 297B | |
+5.34% | 210B | |
-5.97% | 200B | |
-8.18% | 149B | |
-5.32% | 146B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Market Chatter: Preliminary Data Show AstraZeneca COVID-19 Jab Works Against Brazilian Mutation